Aesthetic Medicine in 2026: Plastic Surgery Surges as Med Spa Growth Slows

Aesthetic Medicine in 2026: Plastic Surgery Surges as Med Spa Growth Slows

Oct 2026

The medical aesthetics industry is still growing in 2026, but that growth is far from evenly distributed.

According to Guidepoint Qsight's 2026 research, U.S. patient spending on plastic surgery increased 13% during the first half of 2026, while nonsurgical spending remained nearly flat, growing approximately 1%.

That's a pretty significant difference for an industry that has experienced years of expansion, increasing competition, and changing patient expectations.

The numbers don't suggest Americans are abandoning aesthetic treatments. Instead, they point to a changing market where surgical procedures are experiencing strong demand, certain nonsurgical treatments continue to perform well, and medical spas may need to work harder to attract and retain patients.

Plastic Surgery Is Having a Strong Year

U.S. patient spending on plastic surgery reached $4.7 billion during the first half of 2026, compared with $4.2 billion during the same period in 2025. That's a 13% increase, particularly notable given the economic pressures affecting discretionary consumer spending.

This follows an already strong year for plastic surgery. According to the American Society of Plastic Surgeons (ASPS), cosmetic surgical procedure volume increased 7% in 2025 compared with 2024.

Facial plastic surgery appears to be one of the biggest areas of momentum, particularly procedures such as facelifts, neck lifts, and facial fat grafting. Breast augmentation is also performing well.

What's interesting is that this growth is happening while many nonsurgical treatment categories are struggling to maintain their previous momentum.

There are several possible explanations.

Patients may be placing greater value on longer-lasting results. While injectables and other nonsurgical treatments remain popular, they have limitations. Facelifts, neck lifts, and other surgical procedures can address concerns that nonsurgical treatments simply cannot, particularly when it comes to significant skin laxity or more advanced signs of aging.

Plastic surgery has also become a much more open conversation. More celebrities and public figures are discussing their procedures, and treatments such as facelifts are receiving considerably more mainstream attention. That doesn't necessarily mean everyone is choosing surgery, but it may be helping reduce some of the hesitation surrounding it.

GLP-1 medications may also be contributing to demand. Significant weight loss can result in facial volume loss, loose skin, and other concerns that patients may want to address surgically. According to ASPS, 82% of surveyed member surgeons reported receiving consultation questions related to GLP-1 use in 2025.

That doesn't mean GLP-1 medications are responsible for the overall increase in plastic surgery spending, but it's another factor worth watching as medical weight loss continues to influence the aesthetics industry.

Taken together, these trends suggest that patients are still willing to make substantial investments in their appearance. In some cases, they may simply be choosing different types of treatments.

Nonsurgical Aesthetics Is Telling a Different Story

While plastic surgery spending is growing at double-digit rates, nonsurgical aesthetics has experienced a significant slowdown.

According to Guidepoint Qsight, nonsurgical aesthetic spending growth has steadily slowed, from 5% in 2024 to 3% in 2025 and just 1% during the first half of 2026.

U.S. patient spending reached $10.5 billion during the first six months of 2026, compared with $10.4 billion during the same period in 2025.

The market is still growing, but at a much slower rate than it was just a few years ago.

And while overall spending has remained relatively flat, individual treatment categories are performing quite differently.

Where Nonsurgical Spending Is Growing and Declining

Neurotoxins remain relatively strong, with spending on Botox, Dysport, and similar treatments increasing 5% during the first half of 2026. These treatments continue to benefit from established patient demand and recurring maintenance appointments.

Skin rejuvenation has experienced some of the strongest growth, increasing 13%. This category includes treatments such as traditional microneedling (not RF), chemical peels, and hydradermabrasion rather than lasers or other energy-based procedures. While encouraging, many of these treatments are also among the more affordable services offered by medical spas, meaning strong percentage growth doesn't necessarily translate into comparable revenue increases.

Dermal fillers have experienced continued declines, with spending falling 7% in 2025 and another 3% during the first half of 2026 compared with the same period last year. Traditional hyaluronic acid fillers have been particularly affected, declining 11% in 2025. However, biostimulatory injectables such as Galderma's Sculptra continue to grow, although that growth has not been enough to offset the broader decline in the dermal filler market.

Energy-based treatments, including lasers and RF devices, have experienced mixed performance. According to a joint industry report from Guidepoint Qsight and Skytale Group, spending on energy-based treatments declined 5% in 2024. Qsight's subsequent research also identified weakness in laser hair removal and nonsurgical body contouring during 2025. While early 2026 showed modest improvement, the broader market remains uneven, with skin tightening and resurfacing performing better than body contouring.

Medical weight loss has experienced one of the largest declines, with spending on weight-loss and dietary lifestyle services at aesthetic practices falling 12% during the first half of 2026.

However, this doesn't mean demand for GLP-1 medications is declining. Patients increasingly have access to weight-loss treatment through telehealth providers, direct-to-consumer platforms, and traditional healthcare practices. Companies such as Hims & Hers and Ro have made these services more accessible without requiring an in-person visit to a medical spa.

That distinction matters. Qsight measures spending within aesthetic practices, not the entire medical weight-loss market. The medspa GLP-1 decline reflects patients shifting where they obtain treatment rather than abandoning weight-loss medications altogether.

Overall, these figures paint a mixed picture. Some nonsurgical treatments are holding up well, but others are experiencing downswings. For practices that rely heavily on fillers, energy-based treatments, or medical weight loss, the slowdown may feel considerably more significant than the overall 1% growth figure suggests.

Med Spa Competition Is Outpacing Market Growth

Perhaps the biggest concern for the nonsurgical aesthetics industry isn't simply that patient spending has slowed. It's that medical spas are continuing to expand despite weaker spending growth.

According to Zenoti's 2026 Beauty and Wellness Benchmark Report, medical spa locations grew 18% in 2025 among businesses represented in its data.

Yet the same report found that new patient visits declined 11% and existing patient visits fell 2%.

That's a concerning combination.

More locations are entering the market, but established practices aren't necessarily seeing corresponding increases in patient demand or revenue.

And these figures don't capture the full competitive landscape.

Medical spas aren't competing exclusively with other medical spas. Dermatology practices, plastic surgery practices, and other medical providers from OB-GYNs to dentists also offer many of the same nonsurgical treatments. The number of practices competing for aesthetic patients extends well beyond the medical spa industry itself.

While national figures for new med spa location openings in 2026 aren't yet available, the 2025 data suggests that competition is growing at a time when overall nonsurgical aesthetic spending growth has slowed to approximately 1%.

Increasingly, the answer may be taking market share from competitors rather than relying on the industry itself to grow.

What This Means for Med Spa Marketing in 2026

For years, the rapid expansion of nonsurgical aesthetics helped support new medical spas, additional treatment offerings, and growing patient demand.

Practices could benefit from an expanding market without necessarily having to make significant changes to their marketing strategies.

But that environment is changing.

With nonsurgical patient spending increasing approximately 1% during the first half of 2026, practices can no longer assume that broader industry growth will automatically translate into more patients or revenue.

And as more providers compete for the same patients, maintaining market share may become increasingly difficult.

More Aggressive Marketing May Be Necessary

For many medical spas, maintaining historical growth rates may now require a more aggressive approach to marketing.

That could mean increasing advertising budgets, investing more heavily in local SEO, improving visibility across traditional and AI search platforms, and expanding efforts to attract patients searching for specific treatments.

However, spending more money isn't necessarily the solution on its own.

Practices also need to evaluate which treatments are generating demand, how effectively they're converting leads into bookings, and whether existing patients are returning consistently.

A med spa focused heavily on dermal fillers or medical weight loss may face very different market conditions than one generating substantial revenue from neurotoxins or skin rejuvenation. Marketing strategies and budgets should reflect those differences.

This is also where working with an agency that specializes in medical aesthetics can make a difference.

At Influx Marketing, we work exclusively with medical practices and closely follow industry trends, changes in patient demand, and how consumers search for aesthetic treatments. Understanding what's happening in the market helps us develop more targeted med spa marketing strategies that reflect the challenges and opportunities practices are actually facing.

Patient Retention Is Becoming More Important

In a slower-growing market, retaining existing patients becomes particularly valuable.

Neurotoxins, skincare, and other maintenance-based treatments create opportunities for repeat visits, membership programs, and long-term patient relationships.

Practices that improve retention and increase patient lifetime value may be better positioned to maintain revenue without relying entirely on new-patient acquisition.

But retention alone isn't enough for practices with ambitious growth goals.

Winning additional market share increasingly means convincing patients to choose one provider over another.

The Aesthetic Industry Is Still Growing, but the Opportunities Are Changing

The 2026 numbers don't suggest that aesthetic medicine is in decline. Plastic surgery is experiencing strong growth, while certain nonsurgical treatments, particularly neurotoxins and skin rejuvenation, continue to perform well.

But the broader nonsurgical market is slowing, and competition is increasing.

For plastic surgeons, there's an opportunity to capitalize on growing interest in surgical procedures, particularly facial plastic surgery and breast augmentation. For med spas, the challenge is different.

With patient spending barely increasing and more providers competing for the same patients, growth may increasingly depend on taking market share from competitors.

The opportunity in aesthetic medicine remains substantial, but practices need to be more strategic about where they invest, which treatments they promote, and how they attract and retain patients. The marketing strategies that worked a few years ago may not be enough to deliver the same results today.